Cystatin C Versus Creatinine for GFR Estimation in CKD Due to Heart Failure Delphine Kervella, MD, Sandrine Lemoine, MD, PhD, Florence Sens, MD, Laurence Dubourg, MD, PhD, Laurent Sebbag, MD, PhD, Fitsum Guebre-Egziabher, MD, PhD, Eric Bonnefoy, MD, PhD, Laurent Juillard, MD, PhD American Journal of Kidney Diseases Volume 69, Issue 2, Pages 321-323 (February 2017) DOI: 10.1053/j.ajkd.2016.09.016 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Absolute bias (mGFR − eGFR) for (A) eGFRcr, (B) eGFRcys, and (C) eGFRcr-cys for each patient with CRS2. Results are represented as mean absolute biases (mean of mGFR − eGFR in mL/min/1.73m2, thick broken line) ± 2 standard deviations (thin dotted lines). American Journal of Kidney Diseases 2017 69, 321-323DOI: (10.1053/j.ajkd.2016.09.016) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions